Predictions
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€1.77
05.03.23
05.03.23
-
05.03.24
05.03.24
120.34%
06.03.24
06.03.24
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.62
05.03.23
05.03.23
-
05.03.24
05.03.24
-72.14%
06.03.24
06.03.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€43.60
01.03.23
01.03.23
€68.39
01.03.24
01.03.24
12.84%
02.03.24
02.03.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.05
03.02.24
03.02.24
-
03.02.25
03.02.25
1.90%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Crossject S.A.
Start price
Target price
Perf. (%)
€4.89
30.12.23
30.12.23
€5.50
30.12.24
30.12.24
-22.39%
10.02.24
10.02.24
Could be worthwhile Investment >10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.08
21.01.24
21.01.24
-
21.01.25
21.01.25
21.10%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€3.44
20.01.24
20.01.24
€1.00
20.01.25
20.01.25
3.49%
03.02.24
03.02.24
High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.62
07.01.24
07.01.24
-
07.01.25
07.01.25
-11.80%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
AC Immune Ltd
Start price
Target price
Perf. (%)
€4.16
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.05%
19.01.24
19.01.24
Could be worthwhile Investment >10% per year
Vaxart Inc.
Start price
Target price
Perf. (%)
€1.07
14.01.23
14.01.23
-
14.01.24
14.01.24
-52.68%
15.01.24
15.01.24
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€9.48
30.04.23
30.04.23
-
30.04.24
30.04.24
29.73%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies